This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Email this article to a colleague Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Save to my personal folders Download to citation manager Rights & Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Palmer, S. L. Articles by Mulhern, R. K. Search for Related Content PubMed PubMed Citation Articles by Palmer, S. L. Articles by Mulhern, R. K. Social Bookmarking                            What's this?

Patterns of Intellectual Development Among Survivors of Pediatric Medulloblastoma: A Longitudinal Analysis

From the Division of Behavioral Medicine, Department of Biostatistics and Epidemiology, Department of Diagnostic Imaging, Department of Hematology/Oncology, and Department of Radiation Oncology, St. Jude Children’s Research Hospital; Department of Psychology and Departments of Electrical and Biomedical Engineering, University of Memphis; and Department of Pediatrics, University of Tennessee College of Medicine, Memphis, TN.

Address reprint requests to Shawna L. Palmer, MS, Division of Behavioral Medicine, St. Jude Children’s Research Hospital, 332 N. Lauderdale, Memphis, TN 38105-2794.

PURPOSE: To examine two competing hypotheses relating to intellectual loss among children treated for medulloblastoma (MB): Children with MB either: (1) lose previously learned skills and information; or (2) acquire new skills and information but at a rate slower than expected compared with healthy same-age peers.

PATIENTS AND METHODS: Forty-four pediatric MB patients were evaluated who were treated with postoperative radiation therapy (XRT) with or without chemotherapy. After completion of XRT, a total of 150 examinations were conducted by use of the child version of the Wechsler Intelligence Scales. These evaluations provided a measure of intellectual functioning called the estimated full-scale intelligence quotient (FSIQ). Changes in patient performance corrected for age (scaled scores) as well as the uncorrected performance (raw scores) were analyzed.

RESULTS: At the time of the most recent examination, the obtained mean estimated FSIQ of 83.57 was more than one SD below expected population norms. A significant decline in cognitive performance during the time since XRT was demonstrated, with a mean loss of 2.55 estimated FSIQ points per year (P = .0001). An analysis for the basis of the intelligence quotient (IQ) loss revealed that subtest raw score values increased significantly over time since XRT, but the rate of increase was less than normally expected, which resulted in decreased IQ scores.

CONCLUSION: These results support the hypothesis that MB patients demonstrate a decline in IQ values because of an inability to acquire new skills and information at a rate comparable to their healthy same-age peers, as opposed to a loss of previously acquired information and skills.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Facebook    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				C. Carrie, J. Grill, D. Figarella-Branger, V. Bernier, L. Padovani, J. L. Habrand, M. Benhassel, M. Mege, M. Mahe, P. Quetin, et al. Online Quality Control, Hyperfractionated Radiotherapy Alone and Reduced Boost Volume for Standard Risk Medulloblastoma: Long-Term Results of MSFOP 98 J. Clin. Oncol., April 10, 2009; 27(11): 1879 - 1883. [Abstract] [Full Text] [PDF]

				S. Rutkowski, N. U. Gerber, K. von Hoff, A. Gnekow, U. Bode, N. Graf, F. Berthold, G. Henze, J. E.A. Wolff, M. Warmuth-Metz, et al. Treatment of early childhood medulloblastoma by postoperative chemotherapy and deferred radiotherapy Neuro-oncol, January 1, 2009; 11(2): 201 - 210. [Abstract] [Full Text] [PDF]

				H. M. Conklin, C. Li, X. Xiong, R. J. Ogg, and T. E. Merchant Predicting Change in Academic Abilities After Conformal Radiation Therapy for Localized Ependymoma J. Clin. Oncol., August 20, 2008; 26(24): 3965 - 3970. [Abstract] [Full Text] [PDF]

				D. K. Thotala, D. E. Hallahan, and E. M. Yazlovitskaya Inhibition of Glycogen Synthase Kinase 3{beta} Attenuates Neurocognitive Dysfunction Resulting from Cranial Irradiation Cancer Res., July 15, 2008; 68(14): 5859 - 5868. [Abstract] [Full Text] [PDF]

				K. Yasuda, H. Taguchi, Y. Sawamura, J. Ikeda, H. Aoyama, K. Fujieda, N. Ishii, M. Kashiwamura, Y. Iwasaki, and H. Shirato Low-dose Craniospinal Irradiation and Ifosfamide, Cisplatin and Etoposide for Non-metastatic Embryonal Tumors in the Central Nervous System Jpn. J. Clin. Oncol., July 1, 2008; 38(7): 486 - 492. [Abstract] [Full Text] [PDF]

				M. Gross-King, M. Booth-Jones, and M. Couluris Neurocognitive Impairment in Children Treated for Cancer: How Do We Measure Cognitive Outcomes? Journal of Pediatric Oncology Nursing, July 1, 2008; 25(4): 227 - 232. [Abstract] [PDF]

				S. Phipps, S. N. Rai, W.-H. Leung, S. Lensing, and M. Dunavant Cognitive and Academic Consequences of Stem-Cell Transplantation in Children J. Clin. Oncol., April 20, 2008; 26(12): 2027 - 2033. [Abstract] [Full Text] [PDF]

				S. L. Palmer, W. E. Reddick, and A. Gajjar Understanding the Cognitive Impact on Children Who are Treated for Medulloblastoma J. Pediatr. Psychol., October 1, 2007; 32(9): 1040 - 1049. [Abstract] [Full Text] [PDF]

				K. S. Bull, H. A. Spoudeas, G. Yadegarfar, and C. R. Kennedy Reduction of Health Status 7 Years After Addition of Chemotherapy to Craniospinal Irradiation for Medulloblastoma: A Follow-Up Study in PNET 3 Trial Survivors on Behalf of the CCLG (formerly UKCCSG) J. Clin. Oncol., September 20, 2007; 25(27): 4239 - 4245. [Abstract] [Full Text] [PDF]

				P. C. Nathan, S. K. Patel, K. Dilley, R. Goldsby, J. Harvey, C. Jacobsen, N. Kadan-Lottick, K. McKinley, A. K. Millham, I. Moore, et al. Guidelines for Identification of, Advocacy for, and Intervention in Neurocognitive Problems in Survivors of Childhood Cancer: A Report From the Children's Oncology Group Arch Pediatr Adolesc Med, August 1, 2007; 161(8): 798 - 806. [Abstract] [Full Text] [PDF]

				P. M. Lahteenmaki, A. Harila-Saari, E. I. Pukkala, P. Kyyronen, T. T. Salmi, and R. Sankila Scholastic achievements of children with brain tumors at the end of comprehensive education: A nationwide, register-based study Neurology, July 17, 2007; 69(3): 296 - 305. [Abstract] [Full Text] [PDF]

				J. Spencer The Role of Cognitive Remediation in Childhood Cancer Survivors Experiencing Neurocognitive Late Effects Journal of Pediatric Oncology Nursing, November 1, 2006; 23(6): 321 - 325. [Abstract] [PDF]

				D. J. Mabbott, M. D. Noseworthy, E. Bouffet, C. Rockel, and S. Laughlin Diffusion tensor imaging of white matter after cranial radiation in children for medulloblastoma: Correlation with IQ Neuro-oncol, July 1, 2006; 8(3): 244 - 252. [Abstract] [Full Text] [PDF]

				C. B. Reeves, S. L. Palmer, W. E. Reddick, T. E. Merchant, G. M. Buchanan, A. Gajjar, and R. K. Mulhern Attention and Memory Functioning Among Pediatric Patients with Medulloblastoma J. Pediatr. Psychol., April 1, 2006; 31(3): 272 - 280. [Abstract] [Full Text] [PDF]

				P.-L. Khong, L. H.T. Leung, A. S.M. Fung, D. Y.T. Fong, D. Qiu, D. L.W. Kwong, G.-C. Ooi, G. McAlanon, G. Cao, and G. C.F. Chan White Matter Anisotropy in Post-Treatment Childhood Cancer Survivors: Preliminary Evidence of Association With Neurocognitive Function J. Clin. Oncol., February 20, 2006; 24(6): 884 - 890. [Abstract] [Full Text] [PDF]

				M. Fouladi, E. Gilger, M. Kocak, D. Wallace, G. Buchanan, C. Reeves, N. Robbins, T. Merchant, L. E. Kun, R. Khan, et al. Intellectual and Functional Outcome of Children 3 Years Old or Younger Who Have CNS Malignancies J. Clin. Oncol., October 1, 2005; 23(28): 7152 - 7160. [Abstract] [Full Text] [PDF]

				R. K. Mulhern, S. L. Palmer, T. E. Merchant, D. Wallace, M. Kocak, P. Brouwers, K. Krull, M. Chintagumpala, R. Stargatt, D. M. Ashley, et al. Neurocognitive Consequences of Risk-Adapted Therapy for Childhood Medulloblastoma J. Clin. Oncol., August 20, 2005; 23(24): 5511 - 5519. [Abstract] [Full Text] [PDF]

				P.-L. Khong, L. H. T. Leung, G. C. F. Chan, D. L. W. Kwong, W. H. S. Wong, G. Cao, and G.-C. Ooi White Matter Anisotropy in Childhood Medulloblastoma Survivors: Association with Neurotoxicity Risk Factors Radiology, August 1, 2005; 236(2): 647 - 652. [Abstract] [Full Text] [PDF]

				V. Oyharcabal-Bourden, C. Kalifa, J.C. Gentet, D. Frappaz, C. Edan, P. Chastagner, E. Sariban, A. Pagnier, A. Babin, F. Pichon, et al. Standard-Risk Medulloblastoma Treated by Adjuvant Chemotherapy Followed by Reduced-Dose Craniospinal Radiation Therapy: A French Society of Pediatric Oncology Study J. Clin. Oncol., July 20, 2005; 23(21): 4726 - 4734. [Abstract] [Full Text] [PDF]

				D. J. Mabbott, B. J. Spiegler, M. L. Greenberg, J. T. Rutka, D. J. Hyder, and E. Bouffet Serial Evaluation of Academic and Behavioral Outcome After Treatment With Cranial Radiation in Childhood J. Clin. Oncol., April 1, 2005; 23(10): 2256 - 2263. [Abstract] [Full Text] [PDF]

				S. Rutkowski, U. Bode, F. Deinlein, H. Ottensmeier, M. Warmuth-Metz, N. Soerensen, N. Graf, A. Emser, T. Pietsch, J. E.A. Wolff, et al. Treatment of Early Childhood Medulloblastoma by Postoperative Chemotherapy Alone N. Engl. J. Med., March 10, 2005; 352(10): 978 - 986. [Abstract] [Full Text] [PDF]

				W. E. Reddick, J. O. Glass, S. L. Palmer, S. Wu, A. Gajjar, J. W. Langston, L. E. Kun, X. Xiong, and R. K. Mulhern Atypical white matter volume development in children following craniospinal irradiation Neuro-oncol, January 1, 2005; 7(1): 12 - 19. [Abstract] [PDF]

				B. D. Moore III Neurocognitive Outcomes in Survivors of Childhood Cancer J. Pediatr. Psychol., January 1, 2005; 30(1): 51 - 63. [Abstract] [Full Text] [PDF]

				R. W. Butler and R. K. Mulhern Neurocognitive Interventions for Children and Adolescents Surviving Cancer J. Pediatr. Psychol., January 1, 2005; 30(1): 65 - 78. [Abstract] [Full Text] [PDF]

				P. Brouwers Commentary: Study of the Neurobehavioral Consequences of Childhood Cancer: Entering the Genomic Era? J. Pediatr. Psychol., January 1, 2005; 30(1): 79 - 84. [Full Text] [PDF]

				B. F. Last, M. A. Grootenhuis, and C. Eiser International Comparison of Contributions to Psychosocial Research on Survivors of Childhood Cancer: Past and Future Considerations J. Pediatr. Psychol., January 1, 2005; 30(1): 99 - 113. [Abstract] [Full Text] [PDF]

				S. N. Chi, S. L. Gardner, A. S. Levy, E. A. Knopp, D. C. Miller, J. H. Wisoff, H. L. Weiner, and J. L. Finlay Feasibility and Response to Induction Chemotherapy Intensified With High-Dose Methotrexate for Young Children With Newly Diagnosed High-Risk Disseminated Medulloblastoma J. Clin. Oncol., December 15, 2004; 22(24): 4881 - 4887. [Abstract] [Full Text] [PDF]

				M. Fouladi, M. Chintagumpala, F. H. Laningham, D. Ashley, S. J. Kellie, J. W. Langston, C. W. McCluggage, S. Woo, M. Kocak, K. Krull, et al. White Matter Lesions Detected by Magnetic Resonance Imaging After Radiotherapy and High-Dose Chemotherapy in Children With Medulloblastoma or Primitive Neuroectodermal Tumor J. Clin. Oncol., November 15, 2004; 22(22): 4551 - 4560. [Abstract] [Full Text] [PDF]

				B. J. Nagel, S. L. Palmer, W. E. Reddick, J. O. Glass, K. J. Helton, S. Wu, X. Xiong, L. E. Kun, A. Gajjar, and R. K. Mulhern Abnormal Hippocampal Development in Children with Medulloblastoma Treated with Risk-Adapted Irradiation AJNR Am. J. Neuroradiol., October 1, 2004; 25(9): 1575 - 1582. [Abstract] [Full Text] [PDF]

				A. Gajjar, R. Hernan, M. Kocak, C. Fuller, Y. Lee, P. J. McKinnon, D. Wallace, C. Lau, M. Chintagumpala, D. M. Ashley, et al. Clinical, Histopathologic, and Molecular Markers of Prognosis: Toward a New Disease Risk Stratification System for Medulloblastoma J. Clin. Oncol., March 15, 2004; 22(6): 984 - 993. [Abstract] [Full Text] [PDF]

				B. J. Spiegler, E. Bouffet, M. L. Greenberg, J. T. Rutka, and D. J. Mabbott Change in Neurocognitive Functioning After Treatment With Cranial Radiation in Childhood J. Clin. Oncol., February 15, 2004; 22(4): 706 - 713. [Abstract] [Full Text] [PDF]

				S. L. Wolden, I. J. Dunkel, M. M. Souweidane, L. Happersett, Y. Khakoo, K. Schupak, D. Lyden, and S. A. Leibel Patterns of Failure Using a Conformal Radiation Therapy Tumor Bed Boost for Medulloblastoma J. Clin. Oncol., August 15, 2003; 21(16): 3079 - 3083. [Abstract] [Full Text] [PDF]

				A. P. Kumar, G. E. Garcia, J. Orsborn, V. A. Levin, and T. J. Slaga 2-Methoxyestradiol interferes with NF{kappa}B transcriptional activity in primitive neuroectodermal brain tumors: implications for management Carcinogenesis, February 1, 2003; 24(2): 209 - 216. [Abstract] [Full Text] [PDF]

				S. L. Palmer, W. E. Reddick, J. O. Glass, A. Gajjar, O. Goloubeva, and R. K. Mulhern Decline in Corpus Callosum Volume among Pediatric Patients with Medulloblastoma: Longitudinal MR Imaging Study AJNR Am. J. Neuroradiol., August 1, 2002; 23(7): 1088 - 1094. [Abstract] [Full Text] [PDF]